Economics ❯Market Dynamics ❯Pharmaceutical Industry ❯Drug Costs
The upcoming order seeks to implement a 'most favored nation' model tying U.S. Medicare drug prices to the lowest rates in other wealthy nations, despite legal and political hurdles.
